Journal Title
Title of Journal: Patient
|
Abbravation: The Patient - Patient-Centered Outcomes Research
|
Publisher
Springer International Publishing
|
|
|
|
Authors: Meryl Brod Suzanne Lessard Alolga Luigi Meneghini
Publish Date: 2014/06/24
Volume: 7, Issue: 4, Pages: 437-450
Abstract
The purpose of this study was to identify patient beliefs as well as clinical realities about insulin that may be barriers to type 2 diabetes patients initiating insulin treatment when recommended by their physician This information was then used to develop a clinically relevant crossculturally valid patient education tool with the goal of providing unbiased medically informative statements addressing these barriersThirteen focus groups were conducted in five countries Germany Sweden The Netherlands UK and USA to collect qualitative data on attitudes about insulin therapy from type 2 diabetes patients aged 18 or older whose physician had recommended initiating insulin treatment in the past 6 months n = 87 Additionally a panel of four clinical experts was interviewed to ascertain obstacles they experience in initiating insulin with their patientsOn the basis of the interview data the ten questions that asked about the most important barriers were generated The clinical expert panel then generated clinically accurate and unbiased responses addressing these concerns and the educational tool “Questions about Starting Insulin Information on the Myths Misconceptions and Clinical Realities about Insulin” was drafted The draft tool was pilot tested in a group of patients and finalizedPatient misconceptions as well as some clinical realities about insulin treatment and diabetes can influence the decision to initiate insulin treatment and ultimately impact disease management The educational tool developed through this study was designed to help patients who are deciding whether or not to initiate insulin therapy as recommended by their physician and facilitate patient–healthcare provider interactionsAn educational tool that directly responds to the most common issues raised by patients at this junction has the potential to help facilitate the initiation of insulin treatment sooner improve treatment compliance so that optimal glucose levels can be achieved faster and improve longterm diabetes managementType 2 diabetes mellitus is a chronic progressive illness that affects 347 million people worldwide 1 that when poorly controlled often results in complications including death The World Health Organization estimates that total diabetesrelated deaths will increase by 50 in the next 10 years and has characterized the disease as an epidemic 2
Keywords:
.
|
Other Papers In This Journal:
|